115 related articles for article (PubMed ID: 7699117)
1. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression.
Pilch H; Weiss J; Heubner C; Heine M
J Cutan Pathol; 1994 Dec; 21(6):507-13. PubMed ID: 7699117
[TBL] [Abstract][Full Text] [Related]
2. [A flow cytometric study of the DNA content from paraffin-embedded samples of keratoacanthoma and squamous cell carcinoma].
Hashimoto Y; Matsuo S; Iizuka H
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):701-5. PubMed ID: 1942578
[TBL] [Abstract][Full Text] [Related]
3. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
Turan G; Altun E; Aslan F; Kulahci O
Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis.
Krunic AL; Garrod DR; Smith NP; Orchard GS; Cvijetic OB
Acta Derm Venereol; 1996 Sep; 76(5):394-8. PubMed ID: 8891017
[TBL] [Abstract][Full Text] [Related]
5. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
6. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
7. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
[TBL] [Abstract][Full Text] [Related]
8. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
9. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.
Ioakim-Liossi A; Karakitsos P; Aroni K; Delivelioti K; Fotiou V; Fotiou S; Kyrkou K
Acta Cytol; 1997; 41(6):1714-8. PubMed ID: 9390130
[TBL] [Abstract][Full Text] [Related]
10. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
[TBL] [Abstract][Full Text] [Related]
11. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
Berger F; Geddert H; Faller G; Werner M; Dimmler A
Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
13. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma.
Randall MB; Geisinger KR; Kute TE; Buss DH; Prichard RW
Am J Clin Pathol; 1990 Feb; 93(2):259-62. PubMed ID: 2301286
[TBL] [Abstract][Full Text] [Related]
14. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
15. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
Melendez ND; Smoller BR; Morgan M
Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
[TBL] [Abstract][Full Text] [Related]
16. DNA image cytometry of keratoacanthoma and squamous cell carcinoma.
Herzberg AJ; Kerns BJ; Pollack SV; Kinney RB
J Invest Dermatol; 1991 Sep; 97(3):495-500. PubMed ID: 1875048
[TBL] [Abstract][Full Text] [Related]
17. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
[TBL] [Abstract][Full Text] [Related]
19. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
Hemmer J; Polackova J
Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
[TBL] [Abstract][Full Text] [Related]
20. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
